ovcon 35: Clinical Trials

6 trials of ovcon 35, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Terminated 1

Follow ovcon 35: new trials by email Literature Review of ovcon 35 trials Research Report on ovcon 35

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Drug Interaction Study of Danicopan
Danicopan, Warfarin, Bupropion - Healthy
Phase 1CompletedAlexion Pharmaceuticals, Inc.522019-07-282021-01-14
A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists
Vismodegib, Rosiglitazone, Norethindrone/ethinyl estradiol - Solid Cancers
Phase 1CompletedGenentech, Inc.522010-11-012015-06-29
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions
Norethindrone/Ethinyl Estradiol, FEMCON® Fe - Healthy
Phase 1CompletedTeva Pharmaceuticals USA362008-08-012011-05-30
A Pharmacokinetic Study of Colchicine With an Oral Contraceptive
Norethindrone/Ethinyl Estradiol, Colchicine, Placebo (for Colchicine) - Pharmacokinetics
Phase 1CompletedMutual Pharmaceutical Company, Inc.302007-08-012010-01-05
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions
Norethindrone/Ethinyl Estradiol, Ovcon® 35 Fe - Bioequivalence
Phase 1CompletedTeva Pharmaceuticals USA362006-12-012011-05-25
Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers
Tipranavir low dose, Tipranavir high dose, Ritonavir low dose - Healthy
Phase 1TerminatedBoehringer Ingelheim522002-05-012014-09-19

Sponsors

Teva Pharmaceuticals USA (2)  ·  Alexion Pharmaceuticals, Inc. (1)  ·  Boehringer Ingelheim (1)  ·  Genentech, Inc. (1)  ·  Mutual Pharmaceutical Company, Inc. (1)

Countries

United States (5)

Top investigators

Dawn Colburn, Pharm.D. (1)